Back to Journals » Cancer Management and Research » Volume 12

Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor

Total article views   Abstract views HTML views PDF downloads Totals
1,126 Dovepress* 998 110+ 282 1,108
PubMed Central* 0 18 14 18
Totals 998 128 296 1,126
*Since 12 July 2020
+Since July 2016

View citations on PubMed Central and Google Scholar